Active ingredientFenbufenCat. No. P-F018-001CAS 36330-85-5Family · Pharmaceutical analytical standards
Fenbufen
A non-steroidal anti-inflammatory drug derived from arylbutyric acid, patented as a medicine in the early 1970s and used for osteoarthritis and inflammatory pain: it is a prodrug that the body converts into biphenylacetic acid (felbinac). This family brings together the active ingredient, labelled standards and other impurities.
Did you know?The molecule had already been described in a 1936 patent and in chemistry papers from 1940, decades before its anti-inflammatory action was put to use.
Go to the active ingredient →Active ingredientFenbufenCat. No. P-F018-001CAS 36330-85-5
Isotopically labelledFenbufen-d9Cat. No. P-F018-002CAS 1189940-96-2
ImpurityFenbufen Impurity 1Cat. No. P-F018-003CAS 6918-68-9
Impurity4-(4-Chlorophenyl)-4-oxobutanoic AcidCat. No. P-F018-004CAS 3984-34-7
ImpurityBiphenylCat. No. P-F018-005CAS 92-52-4
ImpurityFenbufen Ethyl EsterCat. No. P-F018-006CAS 1230-54-2
ImpurityFenbufen Isopropyl EsterCat. No. P-F018-007CAS 2725579-21-3
ImpurityFenbufen Methyl EsterCat. No. P-F018-008CAS 54011-27-7No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceFenbufen CRSEDQM code F0041000Family FenbufenNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.